← Back to Search

JoyPop App for Mental Health Improvement

N/A
Recruiting
Led By Aislin R Mushquash, Ph.D.
Research Sponsored by Lakehead University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up treatment readiness subscale of the motivation for youth's treatment scale will be administered at baseline (pre), after 2 weeks (mid), and after 4 weeks (post)
Awards & highlights

Study Summary

This trial will see if an app can improve mental health outcomes for Indigenous youth in Northwestern Ontario while they wait for services.

Who is the study for?
This trial is for Indigenous transitional-aged youth (18-25 years old) in Northwestern Ontario who are on the wait-list for mental health services. Participants must be able to attend an orientation and have access to an iOS device, although a loaner iPhone with the JoyPop app will be provided if needed.Check my eligibility
What is being tested?
The study is testing the effectiveness of a mental health app called JoyPop, designed to help with emotion regulation. It's being compared against usual practice while participants await mental health services. The comparison is done through a randomized controlled trial.See study design
What are the potential side effects?
Since this intervention involves using a mobile app for emotional support, there may not be direct side effects like those associated with medications; however, potential indirect effects could include increased screen time or reliance on digital tools for emotional regulation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~strengths and difficulties questionnaire will be administered at baseline (pre), after 2 weeks (mid), and after 4 weeks (post)
This trial's timeline: 3 weeks for screening, Varies for treatment, and strengths and difficulties questionnaire will be administered at baseline (pre), after 2 weeks (mid), and after 4 weeks (post) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in emotion regulation (awareness)
Change in emotion regulation (clarity)
Change in emotion regulation (goals)
+4 more
Secondary outcome measures
Change in anxious symptoms
Change in depressive symptoms
Change in psychological distress
+8 more
Other outcome measures
App quality (aesthetics)
App quality (engagement)
App quality (functionality)
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Practice + JoyPopExperimental Treatment1 Intervention
Participants will be monitored through the existing wait-list practices, which involve regular phone calls to check in and assess functioning, and will receive access to the JoyPop app for 4 weeks.
Group II: Usual PracticeActive Control1 Intervention
Participants will be monitored through existing wait-list practices which involve regular phone calls to check in and assess functioning. After 4 weeks in the Usual Practice condition, participants will be offered access to the JoyPop app.

Find a Location

Who is running the clinical trial?

Lakehead UniversityLead Sponsor
24 Previous Clinical Trials
3,883 Total Patients Enrolled
4 Trials studying Anxiety
450 Patients Enrolled for Anxiety
Dilico Anishinabek Family CareUNKNOWN
1 Previous Clinical Trials
110 Total Patients Enrolled
1 Trials studying Anxiety
110 Patients Enrolled for Anxiety
Aislin R Mushquash, Ph.D.Principal InvestigatorLakehead University
1 Previous Clinical Trials
110 Total Patients Enrolled
1 Trials studying Anxiety
110 Patients Enrolled for Anxiety

Media Library

Usual Practice + JoyPop Clinical Trial Eligibility Overview. Trial Name: NCT05991154 — N/A
Anxiety Research Study Groups: Usual Practice + JoyPop, Usual Practice
Anxiety Clinical Trial 2023: Usual Practice + JoyPop Highlights & Side Effects. Trial Name: NCT05991154 — N/A
Usual Practice + JoyPop 2023 Treatment Timeline for Medical Study. Trial Name: NCT05991154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overarching objective of this trial?

"This clinical trial, which uses the Difficulties in Emotion Regulation Scale - Short Form to measure progress over a four week period, aims to assess any shifts in emotion regulation that may have occurred. Secondary outcomes such as changes in depressive symptoms (as measured by Depression subscale of the Depression Anxiety and Stress Scale 21), anxious symptoms (measured with the Anxiety subscale of the Depression Anxiety and Stress Scale 21) and stress levels (assessed using the Stress subscale of the Depression Anxiety and Stress Scale 21) will also be examined."

Answered by AI

Are octogenarians being accepted into this trial?

"This trial only welcomes patients aged 18 to 25. However, there are 285 studies for minors and 1104 ones that target seniors."

Answered by AI

Are there any enrollment opportunities available for this research endeavor?

"This medical trial, first posted on August 31st 2023, is not actively seeking out participants. Recent updates from clinicaltrials.gov have rendered this study inactive; however, there are 1,535 other trials that are currently recruiting patients."

Answered by AI

Does my medical profile make me a suitable candidate for this research?

"This clinical trial seeks 110 volunteers between 18-25 years of age who are suffering from anxiety."

Answered by AI
~51 spots leftby Dec 2024